# Dermatology

## Main Conditions

- [Atopic dermatitis](/content/dermatology/atopic-dermatitis/index.html)
- [Psoriasis](/content/dermatology/psoriasis/index.html)
- [Actinic keratosis](/content/dermatology/actinic-keratosis/index.html)
- [Acne](/content/dermatology/acne/index.html)
- Other skin conditions
  - [Onychomycosis](/content/dermatology/onychomycosis/index.html)
  - [Alopecia areata](/content/dermatology/alopecia-areata/index.html)
  - [Keratinocyte cancer](/content/dermatology/keratinocyte-cancer/index.html)
  - [Vitiligo](/content/dermatology/vitiligo/index.html)
  - [Hidradenitis suppurativa](/content/dermatology/hidradenitis-suppurativa/index.html)
  - [Rare skin diseases](/content/dermatology/rare-skin-diseases/index.html)

## Our Commitment to Science and Innovation

## Financial Data

### H1 2026 Financial Results

- [H1 2026 Financial Results presentation](https://blob.almirall.com/files/2026-07/EN-Financial_Results_Business_Update_H1-2026-vFinal.pdf)
- [Q1 2026 Financial Results presentation](https://blob.almirall.com/files/2026-05/EN-Financial_Results_Business_Update_Q1-2026-vFinal.pdf)
- [FY 2025 Financial Results presentation](https://blob.almirall.com/files/2026-05/Financial_Results_Business_Update_ENG_FY2025_Final.pdf)

## Calendar Events

- **24 JUL 2026**: H1 2026 Financial Results  
  
- **09 NOV 2026**: 9M 2026 Financial Results

## Annual General Shareholders Meeting

- **07 May 2026**:  Annual General Meeting of Shareholders

## Corporate Governance

- [Learn more about our corporate governance](/content/investors/corporate-governance/index.html)

## Contact Us

**Pablo Divasson del Fraile**  
Investors relations  
Ronda General Mitre, 151 - 08022 Barcelona  
[investors@almirall.com](mailto:investors@almirall.com)  
T+ 34 932 913 000

## Sustainability  
Committed to people and the planet.